Amneal Pharmaceuticals, Inc.
AMRXDrugs in Pipeline
9
Phase 3 Programs
9
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
Phenazopyridine Hydrochloride Tables, USP 200 mg
Uncomplicated Urinary Tract Infections
Testosterone Topical Gel, 1.62% Metered Pump
Primary Hypogonadism
Estradiol Vaginal Tablets 10 mcg
Atrophic Vaginitis Due to Menopause
Asenapine Sublingual Tablets 10 mg
Schizophrenia
Imatinib Mesylate Tablets, 400 mg
Chronic Myeloid Leukemia
Phenazopyridine Hydrochloride
Pain
Mometasone Furoate Nasal Spray, 50 mcg
Seasonal Allergic Rhinitis
Test - Bimatoprost 0.01% Ophthalmic Solution
Glaucoma, Open-Angle
Diclofenac Sodium Topical Gel, 1%
Osteoarthritis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Phenazopyridine Hydrochloride Tables, USP 200 mg | Phase 3 | Uncomplicated Urinary Tract Infections | - | - |
Testosterone Topical Gel, 1.62% Metered Pump | Phase 3 | Primary Hypogonadism | - | - |
Estradiol Vaginal Tablets 10 mcg | Phase 3 | Atrophic Vaginitis Due to Menopause | - | - |
Asenapine Sublingual Tablets 10 mg | Phase 3 | Schizophrenia | - | - |
Imatinib Mesylate Tablets, 400 mg | Phase 3 | Chronic Myeloid Leukemia | - | - |
Phenazopyridine Hydrochloride | Phase 3 | Pain | - | - |
Mometasone Furoate Nasal Spray, 50 mcg | Phase 3 | Seasonal Allergic Rhinitis | - | - |
Test - Bimatoprost 0.01% Ophthalmic Solution | Phase 3 | Glaucoma, Open-Angle | - | - |
Diclofenac Sodium Topical Gel, 1% | Phase 3 | Osteoarthritis | - | - |